Biocon Biologics Teams Up With Civica On US Insulin Production
Indian Firm Will Supply Insulin Aspart Drug Substance For Manufacturing In US
Biocon Biologics is partnering with Civica to supply insulin aspart drug substance that will be used for final US manufacturing by Civica at its plant in Petersburg, Virginia.
